For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

< Back to Agenda
Enabling Patient Access: Identifying Disruptive Technologies in CGT
Thursday, May 30, 2024 08:00 AM - 09:00 AM  
Room 205-207
Roundtable
Organized by: ISCT Industry Committee

Moderator
  • Vincenzo Di Cerbo, PhD, Cell and Gene Therapy Catapult, United Kingdom 
Panelists
  • Jason Foster, Ori Biotech, United States/United Kingdom
  • Lee Buckler, Cell Therapy Group, Canada
  • ​Qasim Rafiq, PhD, University College London, United Kingdom
  • Susan B. Nichols, BSc., Propel Bio, LLC, United States
Recognize high-potential technologies that will increase product manufacturability and scalability, reduce cost of goods, and improve quality in the CGT sector.

Key Learning Objectives
1. Understanding of underdeveloped technological areas
2. Understanding of high-potential technological areas
3. Recognizing whether trends in technology investments match high-potential areas


 
Vincenzo Di Cerbo
Lead Scientist
 Cell and Gene Therapy Catapult
 Moderator
Jason C Foster
Chief Executive Officer
 Ori Biotech
 Panelist
Lee Buckler
SVP Advanced Therapies
 Blood Centers of America
 Panelist
Qasim Rafiq
Professor
 University College London
 Panelist
Susan Nichols
CEO
 Propel Bio LLC
 Panelist
< Back to Agenda